Pharmaceuticals

Global Leukapheresis Market Forecast 2026–2035: Long-Term Growth Insights

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the leukapheresis market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Leukapheresis Market be in 2030 compared with 2026?

The leukapheresis market has shown significant expansion in recent years. It is projected to grow from $72.02 billion in 2025 to $77.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. This historical growth can be attributed to factors such as an increase in hematologic disorders, the expansion of cancer research programs, the increasing utilization of apheresis in blood centers, advancements in centrifugation technologies, and a rise in clinical research funding.

The leukapheresis market is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $104.27 billion, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion during the projection period is primarily driven by factors such as the advancements in CAR-T and cell-based therapies, heightened investment in immunology research, a surge in the need for personalized medicine, the broadening scope of biopharmaceutical manufacturing, and continuous technological improvements in apheresis automation. Key developments expected within this timeframe involve the escalating application of leukapheresis in cell and gene therapies, a greater requirement for immune cell collection in cancer treatment, the expanding implementation of automated apheresis systems, the wider integration of leukapheresis in clinical studies, and an elevated emphasis on patient-friendly disposable apheresis kits.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Drivers Are Guiding Growth Patterns In The Leukapheresis Market?

The leukapheresis market is anticipated to expand due to the increasing prevalence of autoimmune diseases. These medical conditions occur when the immune system erroneously targets and harms the body’s own healthy tissues. Factors such as decreased microbial exposure in early life and contemporary environmental influences are disrupting immune equilibrium, resulting in a higher incidence of autoimmune disorders. Leukapheresis offers a therapeutic approach for autoimmune conditions by specifically extracting the detrimental white blood cells responsible for the immune system’s attack on the body’s own tissues. For example, data from GetValue.co, a US-based online digital platform, indicated in September 2025 that autoimmune diseases impact an estimated 3–10% of the world’s population, which translates to approximately 600–800 million individuals globally. Consequently, the growing occurrence of autoimmune diseases is significantly boosting the expansion of the leukapheresis market.

Which Segments Are Driving Activity In The Leukapheresis Market?

The leukapheresis market covered in this report is segmented –

1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

Which Competitive Trends Are Impacting The Structure Of The Leukapheresis Market?

Leading companies active in the leukapheresis market are prioritizing advancements such as the development of GMP-grade leukopaks to enhance the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are products derived from leukapheresis and processed under strict good manufacturing practice (GMP) standards, ensuring the high viability and functionality of collected cells for therapeutic uses. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, introduced LeukoCer, a GMP-grade leukopak created to streamline workflows and accelerate cell therapy development. LeukoCert offers superior quality starting materials, available in fresh whole or half packs, produced in accordance with stringent GMP standards, thereby empowering researchers to advance their studies and bring novel cell therapies to market more quickly.

Which Major Industry Participants Are Leading The Leukapheresis Market Growth?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Leukapheresis Market?

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Leukapheresis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Market 2026, By The Business Research Company

Leqembi Market Report 2026

https://www.thebusinessresearchcompany.com/report/leqembi-global-market-report

Leukemia Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Chronic Myeloid Leukemia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795